| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 1,8 M € | +22.4% | 1,5 M € | -0.3% | 1,5 M € | +19.2% | 1,2 M € | -26.3% | 1,7 M € | -12.8% | 1,9 M € | +8.6% | 1,8 M € | -8.4% | 2,0 M € | -25.0% | 2,6 M € | ||||||||
| Gross margin | 1,2 M € | +7.6% | 1,1 M € | -11.1% | 1,2 M € | +53.6% | 800,8 k € | -11.4% | 903,9 k € | +6.1% | 851,9 k € | -13.7% | 987,5 k € | — | — | — | — | — | — | — | — | — | ||||||||||
| EBITDA | 113,5 k € | +131.4% | 49,0 k € | -88.4% | 421,0 k € | +825.1% | 45,5 k € | +119.6% | 20,7 k € | +49.2% | 13,9 k € | -66.7% | 41,7 k € | -89.9% | 412,6 k € | +2140.0% | 18,4 k € | -57.8% | 43,7 k € | +131.2% | -139,8 k € | -147.3% | 295,7 k € | -30.1% | 423,1 k € | +16.2% | 364,1 k € | -25.7% | 489,8 k € | -15.8% | 581,6 k € | |
| Operating profit | 77,5 k € | +483.4% | 13,3 k € | -96.5% | 383,1 k € | +6957.0% | 5,4 k € | +155.4% | -9,8 k € | +63.2% | -26,6 k € | -819.7% | 3,7 k € | -99.0% | 378,4 k € | +1890.6% | -21,1 k € | -1668.7% | -1,2 k € | +99.3% | -183,0 k € | -173.5% | 249,2 k € | -31.2% | 362,2 k € | +18.9% | 304,6 k € | -27.4% | 419,3 k € | -18.4% | 514,2 k € | |
| Profit/loss | 47,3 k € | +2548.3% | -1,9 k € | -100.7% | 272,2 k € | +7322.3% | -3,8 k € | +79.6% | -18,4 k € | +18.2% | -22,6 k € | -1485.9% | 1,6 k € | -99.3% | 242,7 k € | +6650.9% | 3,6 k € | -67.9% | 11,2 k € | -55.6% | 25,2 k € | -85.5% | 173,5 k € | -30.3% | 248,8 k € | +17.2% | 212,3 k € | -29.4% | 300,8 k € | -16.6% | 360,8 k € | |
| Equity | 1,0 M € | +4.9% | 973,8 k € | -0.2% | 975,7 k € | +38.7% | 703,5 k € | -36.5% | 1,1 M € | -1.6% | 1,1 M € | -2.0% | 1,1 M € | +0.1% | 1,1 M € | +26.8% | 905,4 k € | +0.4% | 901,8 k € | -30.1% | 1,3 M € | +2.0% | 1,3 M € | +15.9% | 1,1 M € | +29.5% | 843,0 k € | +0.2% | 841,1 k € | +0.1% | 840,6 k € | |
| Total assets | 1,5 M € | -6.9% | 1,6 M € | +6.1% | 1,5 M € | +48.7% | 1,0 M € | -31.5% | 1,5 M € | +3.4% | 1,4 M € | -2.3% | 1,5 M € | -8.8% | 1,6 M € | +24.3% | 1,3 M € | -20.3% | 1,6 M € | +4.4% | 1,6 M € | -3.1% | 1,6 M € | -8.4% | 1,7 M € | +33.9% | 1,3 M € | -7.3% | 1,4 M € | -9.1% | 1,5 M € | |
| Cash | 151,6 k € | +2.4% | 148,0 k € | -66.7% | 445,2 k € | +441.7% | 82,2 k € | -83.3% | 491,2 k € | +11.6% | 440,3 k € | +6.6% | 412,9 k € | -7.8% | 447,8 k € | +201.3% | 148,6 k € | +46.2% | 101,6 k € | +326.2% | 23,8 k € | -91.5% | 278,9 k € | +90.1% | 146,7 k € | +76.9% | 82,9 k € | -66.7% | 248,6 k € | -13.9% | 288,7 k € | |
| Debts | 466,6 k € | -25.2% | 623,9 k € | +17.7% | 530,2 k € | +71.6% | 308,9 k € | -16.4% | 369,3 k € | +22.4% | 301,8 k € | -3.5% | 312,6 k € | -31.4% | 455,6 k € | +18.3% | 385,1 k € | -46.3% | 717,3 k € | +177.6% | 258,4 k € | -21.2% | 328,1 k € | -49.1% | 644,1 k € | +43.7% | 448,3 k € | -19.0% | 553,6 k € | -20.2% | 694,0 k € | |
| Staff | 15,9 | 14,9 | 13,5 | 12,6 | 15,6 | 15 | 16,2 | 16,7 | 16,2 | 16,1 | 16,9 | 17,8 | 18,9 | 17,3 | 19,1 | 18,6 | ||||||||||||||||
Public limited company · Izegem · incorporated on 23/12/1982 · 15,9 ETP
Public limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CLEMENT PHARMA is a Public limited company incorporated in 1982. Its main activity is: Manufacture of furniture. Its registered office is in Izegem. It employs on average 15,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette